Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil.

Authors :: Donadel CD
De Santis GC
Gonçalves TE
Pires BG
Palma LC
Gava F
Guerino-Cunha RL
Faria JTB
Silva GVA
Darrigo-Junior LG
Fatobene G
Rocha V
Covas DT
Calado RT
Clé DV
Source :: Bone marrow transplantation [Bone Marrow Transplant] 2024 Jul; Vol. 59 (7), pp. 1040-1042. Date of Electronic Publication: 2024 Apr 13.
Publication Year :: 2024

Subjects :: Humans
Brazil
Male
Female
Adult
Middle Aged
Receptors, Chimeric Antigen therapeutic use
Adolescent
Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy
Lymphoma, Non-Hodgkin therapy
Antigens, CD19 immunology
Antigens, CD19 therapeutic use
Immunotherapy, Adoptive methods

Full Text Access

Tools